+ +

•  

   

     Western blot analysis of Olig1 expression in MOLT4 cell lysate.    

  
  

Olig1 antibody is a crucial tool in neuroscience research, primarily targeting the Olig1 protein, a basic helix-loop-helix (bHLH) transcription factor. Olig1 is a member of the Olig family (Olig1. Olig2. Olig3) and plays a pivotal role in the development and differentiation of oligodendrocytes, the myelinating cells of the central nervous system (CNS). It is essential for oligodendrocyte lineage specification, myelination, and remyelination processes. Olig1 is predominantly expressed in the CNS, with its activity linked to neural progenitor cells during embryogenesis and in adult stem cell niches.

Researchers use Olig1 antibodies to identify oligodendrocyte precursors and mature oligodendrocytes in tissue samples, aiding studies on demyelinating diseases (e.g., multiple sclerosis) and brain tumors (e.g., gliomas). The antibody is widely applied in techniques like immunohistochemistry (IHC), immunofluorescence (IF), and Western blotting. Its specificity is validated through knockout controls or RNA interference to ensure accurate detection.

Olig1's dual role in promoting myelination and suppressing astrocyte differentiation makes it a key target in regenerative medicine. Dysregulation of Olig1 is associated with neurodevelopmental disorders and glioma progression, highlighting its diagnostic and therapeutic relevance. Commercial Olig1 antibodies are typically raised in hosts like rabbits or mice, with clones validated for cross-reactivity in human, mouse, and rat specimens. Proper validation remains critical due to potential cross-reactivity with Olig2 in some cases.